CD82 抗体
(CD82)
This metastasis suppressor gene product is a membrane glycoprotein that is a member of the transmembrane 4 superfamily. Expression of this gene has been shown to be downregulated in tumor progression of human cancers and can be activated by p53 through a consensus binding sequence in the promoter. Its expression and that of p53 are strongly correlated, and the loss of expression of these two proteins is associated with poor survival for prostate cancer patients. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| CD82 抗体 (AA 98-267) (PE) | 人 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (AA 32-266) (PE) | 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (AA 32-266) (Fluoro647) | 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (AA 98-267) (Fluoro647) | 人 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (C-Term) | 人 | 兔 Polyclonal |
|
|
|
| CD82 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| CD82 抗体 | 人 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (FITC) | 人 | 小鼠 Monoclonal |
|
|
|
| CD82 抗体 (PE) | 人 | 小鼠 Monoclonal |
|
|
|
| CD82 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| CD82 抗体 (Biotin) | 人 | 小鼠 Monoclonal |
|
|
|
| CD82 抗体 (AA 111-228) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (AA 111-227) (FITC) | 小鼠 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (Alexa Fluor 680) | 人 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (Alexa Fluor 680) | 小鼠 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (Alexa Fluor 555) | 人 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (Alexa Fluor 555) | 小鼠 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (Alexa Fluor 647) | 人 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (Alexa Fluor 647) | 小鼠 | 兔 Polyclonal |
|
|
|
| CD82 抗体 (Alexa Fluor 750) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 98-267
Primary Antibody
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 32-266
Primary Antibody
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- AA 32-266
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Fluoro647
- 抗体亚型
- IgG
- 抗原表位
- AA 98-267
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 239-267, C-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IF/ICC (Immunofluorescence (fixed cells): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 标记
- FITC
- 抗体亚型
- IgG2a
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IF/ICC (Immunofluorescence (fixed cells): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 标记
- PE
- 抗体亚型
- IgG2a
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IF/ICC (Immunofluorescence (fixed cells): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 标记
- Biotin
- 抗体亚型
- IgG2a
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 111-228
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 111-227
Latest Publications for our CD82 抗体
: "Mycobacterium abscessus alkyl hydroperoxide reductase C promotes cell invasion by binding to tetraspanin CD81." in: iScience, Vol. 26, Issue 2, pp. 106042, (2023) (PubMed).
: "Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression." in: OncoTargets and therapy, Vol. 10, pp. 1827-1834, (2017) (PubMed).
: "Rapid multiplex analysis of lipid raft components with single-cell resolution." in: Science signaling, Vol. 8, Issue 395, pp. rs11, (2015) (PubMed).
: "Overexpression and Nucleolar Localization of ?-Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma." in: Journal of neuropathology and experimental neurology, Vol. 74, Issue 7, pp. 723-42, (2015) (PubMed).
: "The DSCs-expressed CD82 controls the invasiveness of trophoblast cells via integrinbeta1/MAPK/MAPK3/1 signaling pathway in human first-trimester pregnancy." in: Biology of reproduction, Vol. 82, Issue 5, pp. 968-79, (2010) (PubMed).
: "Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications." in: The American journal of pathology, Vol. 170, Issue 1, pp. 126-39, (2007) (PubMed).
: "Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 21, Issue 3, pp. 691-9, (2007) (PubMed).
: "KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line." in: Biochemical and biophysical research communications, Vol. 342, Issue 2, pp. 655-61, (2006) (PubMed).
: "The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity." in: Cancer research, Vol. 64, Issue 20, pp. 7455-63, (2004) (PubMed).
: "The metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through reactive oxygen intermediates." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 18, Issue 1, pp. 158-60, (2004) (PubMed).
: "Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression." in: OncoTargets and therapy, Vol. 10, pp. 1827-1834, (2017) (PubMed).
: "Rapid multiplex analysis of lipid raft components with single-cell resolution." in: Science signaling, Vol. 8, Issue 395, pp. rs11, (2015) (PubMed).
: "Overexpression and Nucleolar Localization of ?-Tubulin Small Complex Proteins GCP2 and GCP3 in Glioblastoma." in: Journal of neuropathology and experimental neurology, Vol. 74, Issue 7, pp. 723-42, (2015) (PubMed).
: "The DSCs-expressed CD82 controls the invasiveness of trophoblast cells via integrinbeta1/MAPK/MAPK3/1 signaling pathway in human first-trimester pregnancy." in: Biology of reproduction, Vol. 82, Issue 5, pp. 968-79, (2010) (PubMed).
: "Expression of the metastasis suppressor KAI1 in decidual cells at the human maternal-fetal interface: Regulation and functional implications." in: The American journal of pathology, Vol. 170, Issue 1, pp. 126-39, (2007) (PubMed).
: "Overexpression of tetraspanins affects multiple myeloma cell survival and invasive potential." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 21, Issue 3, pp. 691-9, (2007) (PubMed).
: "KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line." in: Biochemical and biophysical research communications, Vol. 342, Issue 2, pp. 655-61, (2006) (PubMed).
: "The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity." in: Cancer research, Vol. 64, Issue 20, pp. 7455-63, (2004) (PubMed).
: "The metastasis suppressor gene C33/CD82/KAI1 induces apoptosis through reactive oxygen intermediates." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 18, Issue 1, pp. 158-60, (2004) (PubMed).
Aliases for CD82 抗体
CD82 antigen (Cd82) 抗体CD82 molecule (CD82) 抗体
Cd82 molecule (Cd82) 抗体
4F9 抗体
AA682076 抗体
AL023070 抗体
C33 抗体
GR15 抗体
IA4 抗体
Kai1 抗体
KAI1 抗体
R2 抗体
SAR2 抗体
ST6 抗体
Tspan27 抗体
TSPAN27 抗体
您还需要查找其他产品吗？
You are here:
